GLIPIZIDE Side Effects

7019995-5 | Hypoglycaemia, Malaise
on Aug 31, 2010 Male patient from UNITED STATES , 58 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Glipizide (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia, malaise. Glipizide dosage: 10 Mg Daily, Oral. During the same period patient was treated with METFORMIN HCL (1000 Mg Bid, Oral; 500 Mg Bid, Oral) (View Metformin Hcl Review and Metformin Hcl Label ), ROSUVASTATIN (ROSUVASTATIN) (ROSUVASTATIN) (View Rosuvastatin (rosuvastatin) (rosuvastatin) Review and Rosuvastatin (rosuvastatin) (rosuvastatin) Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), GABAPENTIN (GABAPENTIN) (GABAPENTIN) (View Gabapentin (gabapentin) (gabapentin) Review and Gabapentin (gabapentin) (gabapentin) Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ).

7017636-4 | Liver Injury
Patient was taking Glipizide (View Usage). Patient had the following side effects: liver injury on Sep 22, 2010 from UNITED STATES Additional patient health information: Male patient , 49 years of age, . Glipizide dosage: Twice A Day. During the same period patient was treated with METFORMIN HCL (1000 Mg, 2x/day) (View Metformin Hcl Review and Metformin Hcl Label ), LANTUS (70 Units) (View Lantus Review and Lantus Label ).

7012723-9 | Blood Glucose Abnormal
Adverse event was reported on Jun 25, 2010 by a Male patient taking Glipizide (View Usage) (Dosage: 2.5 Mg, 2x/day, Oral) was diagnosed with blood glucose increased and. Location: UNITED STATES , 70 years of age, weighting 179.9 lb, After Glipizide was administered, patient had the following side effects: blood glucose abnormal. During the same period patient was treated with PRAVASTATIN (PRAVASTANTIN) (View Pravastatin (pravastantin) Review and Pravastatin (pravastantin) Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ).

7012722-7 | Diabetes Mellitus Inadequate Control
on Mar 15, 2010 Female patient from UNITED STATES , 75 years of age, weighting 235.9 lb, was diagnosed with diabetes mellitus and was treated with Glipizide (View Usage). Patient experienced the following unwanted or unexpected effects: diabetes mellitus inadequate control. Glipizide dosage: 5 Mg, 2x/day, Oral. During the same period patient was treated with ACTOS (View Actos Review and Actos Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), XALATAN (View Xalatan Review and Xalatan Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), DORZOLAMIDE HYDROCHLORIDE/TIMOLOL MALEATE (DORZOLAMIDE HYDROCHLORIDE, (View Dorzolamide Hydrochloride/timolol Maleate (dorzolamide Hydrochloride, Review and Dorzolamide Hydrochloride/timolol Maleate (dorzolamide Hydrochloride, Label ), WELCHOL (View Welchol Review and Welchol Label ), VALSARTAN (View Valsartan Review and Valsartan Label ).


7012694-5 | Alopecia, Blood Glucose Decreased, Urine Odour Abnormal
on Feb 11, 2010 Female patient from UNITED STATES , 67 years of age, weighting 220.0 lb, was diagnosed with diabetes mellitus and was treated with Glipizide (View Usage). Patient had the following side effects: alopecia, blood glucose decreased, urine odour abnormal. Glipizide dosage: 10 Mg, 3x/day, Oral. During the same period patient was treated with DILTIAZEM (View Diltiazem Review and Diltiazem Label ), TIMOLOL MALEATE (View Timolol Maleate Review and Timolol Maleate Label ).

7012591-5 | Diabetes Mellitus Inadequate Control
Patient was taking Glipizide (View Usage). After Glipizide was administered, patient had the following side effects: diabetes mellitus inadequate control on May 21, 2010 from UNITED STATES Additional patient health information: Male patient , 49 years of age, was diagnosed with type 2 diabetes mellitus and. Glipizide dosage: . During the same period patient was treated with LANTUS (50 Iu, 1x/day) (View Lantus Review and Lantus Label ), ACTOS (View Actos Review and Actos Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ).

7003427-7 | Painful Defaecation
Adverse event was reported on Aug 20, 2010 by a Female patient taking Glipizide (View Usage) (Dosage: 5 Mg, 1x/day) was diagnosed with diabetes mellitus and. Location: UNITED STATES , weighting 185.0 lb, Patient experienced the following unwanted or unexpected effects: painful defaecation. During the same period patient was treated with HYDROCHLOROTHIAZIDE (12.5 Mg, Unk) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), WELLBUTRIN XL (300 Mg, Unk) (View Wellbutrin Xl Review and Wellbutrin Xl Label ), PRAVASTATIN (40 Mg, Unk) (View Pravastatin Review and Pravastatin Label ), ZEGERID (Unk) (View Zegerid Review and Zegerid Label ), AMBIEN (12.5 Mg, Unk) (View Ambien Review and Ambien Label ).

6994677-4 | Blood Glucose Increased, Hypoglycaemia
on Aug 31, 2010 Male patient from UNITED STATES , 58 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Glipizide (View Usage). Patient had the following side effects: blood glucose increased, hypoglycaemia. Glipizide dosage: 10 Mg Daily, Oral. During the same period patient was treated with METFORMIN HCL (1000 Mg Bid, Oral, 500 Mg Bid, Oral) (View Metformin Hcl Review and Metformin Hcl Label ), ROSUVASTATIN (ROSUVASTATIN) (ROSUVASTATIN) (View Rosuvastatin (rosuvastatin) (rosuvastatin) Review and Rosuvastatin (rosuvastatin) (rosuvastatin) Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), GABAPENTIN (GABAPENTIN) (GABAPENTIN) (View Gabapentin (gabapentin) (gabapentin) Review and Gabapentin (gabapentin) (gabapentin) Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), NABUMETONE (NABUMETONE) (NABUMETONE) (View Nabumetone (nabumetone) (nabumetone) Review and Nabumetone (nabumetone) (nabumetone) Label ).

6979521-3 | Hypoglycaemia, Mental Status Changes
on Sep 10, 2010 Male patient from UNITED STATES , 54 years of age, weighting 145.5 lb, was diagnosed with type 2 diabetes mellitus and was treated with Glipizide (View Usage). After Glipizide was administered, patient had the following side effects: hypoglycaemia, mental status changes. Glipizide dosage: 5 Mg Bid Po. Patient was hospitalized.

6963978-8 | Diabetes Mellitus Inadequate Control, Product Substitution Issue
Patient was taking Glipizide (View Usage). Patient experienced the following unwanted or unexpected effects: diabetes mellitus inadequate control, product substitution issue on Sep 02, 2010 from UNITED STATES Additional patient health information: Male patient , 62 years of age, weighting 200.0 lb, was diagnosed with diabetes mellitus and. Glipizide dosage: 1 Tab Bid Po.

6914850-0 | Angioedema
Adverse event was reported on Aug 04, 2010 by a Male patient taking Glipizide (View Usage) (Dosage: 2.5 Mg Bid Po) was diagnosed with diabetes mellitus and. Location: UNITED STATES , 61 years of age, weighting 207.0 lb, Patient had the following side effects: angioedema.

6913180-0 | Alopecia, Blood Glucose Decreased, Urine Odour Abnormal
on Feb 11, 2010 Female patient from UNITED STATES , weighting 220.0 lb, was diagnosed with diabetes mellitus, hypertension, glaucoma (What is glaucoma?) and was treated with Glipizide (View Usage). After Glipizide was administered, patient had the following side effects: alopecia, blood glucose decreased, urine odour abnormal. Glipizide dosage: 10 Mg, 3x/day. During the same period patient was treated with DILTIAZEM (View Diltiazem Review and Diltiazem Label ), TIMOLOL (View Timolol Review and Timolol Label ).

6913171-X | Blood Glucose Increased
on Mar 15, 2010 Male patient from UNITED STATES , weighting 210.1 lb, was diagnosed with type 2 diabetes mellitus and was treated with Glipizide (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased. Glipizide dosage: 5 Mg, 1x/day. During the same period patient was treated with GLUCOPHAGE (View Glucophage Review and Glucophage Label ), CELEBREX (View Celebrex Review and Celebrex Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), NIASPAN (View Niaspan Review and Niaspan Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), ZOCOR (View Zocor Review and Zocor Label ).

6913072-7 | Blood Glucose Increased
Patient was taking Glipizide (View Usage). Patient had the following side effects: blood glucose increased on Jun 22, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 313.1 lb, was diagnosed with blood glucose increased and. Glipizide dosage: Unk. During the same period patient was treated with METFORMIN HCL (Unk) (View Metformin Hcl Review and Metformin Hcl Label ), SITAGLIPTIN (View Sitagliptin Review and Sitagliptin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ).

6913053-3 | Blood Glucose Abnormal, Diabetes Mellitus Inadequate Control
Adverse event was reported on Jun 18, 2009 by a Male patient taking Glipizide (View Usage) (Dosage: 10 Mg, 2x/day) was diagnosed with type 2 diabetes mellitus, blood pressure abnormal and. Location: UNITED STATES , weighting 235.9 lb, After Glipizide was administered, patient had the following side effects: blood glucose abnormal, diabetes mellitus inadequate control. During the same period patient was treated with VALSARTAN (Unk) (View Valsartan Review and Valsartan Label ), AMLODIPINE BESYLATE/VALSARTAN (Unk) (View Amlodipine Besylate/valsartan Review and Amlodipine Besylate/valsartan Label ), HYDRALAZINE (Unk) (View Hydralazine Review and Hydralazine Label ).

6913027-2 | Glycosylated Haemoglobin Increased, Malaise
on Jun 16, 2009 Female patient from UNITED STATES , weighting 257.1 lb, was diagnosed with diabetes mellitus and was treated with Glipizide (View Usage). Patient experienced the following unwanted or unexpected effects: glycosylated haemoglobin increased, malaise. Glipizide dosage: 10 Mg, 2x/day. During the same period patient was treated with SYNTHROID (Unk) (View Synthroid Review and Synthroid Label ), CENTRUM SILVER (Unk) (View Centrum Silver Review and Centrum Silver Label ), ACETYLSALICYLIC ACID (Unk) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), LINSEED OIL (Unk) (View Linseed Oil Review and Linseed Oil Label ), PRINZIDE (Unk) (View Prinzide Review and Prinzide Label ), SIMVASTATIN (Unk) (View Simvastatin Review and Simvastatin Label ), VITACAL (Unk) (View Vitacal Review and Vitacal Label ).

6912921-6 | Abdominal Discomfort, Eructation, Gastrooesophageal Reflux Disease
on Apr 03, 2009 Male patient from UNITED STATES , 77 years of age, was treated with Glipizide (View Usage). Patient had the following side effects: abdominal discomfort, eructation, gastrooesophageal reflux disease. Glipizide dosage: Unk.

6912868-5 | Blood Glucose Increased
Patient was taking Glipizide (View Usage). After Glipizide was administered, patient had the following side effects: blood glucose increased on Feb 19, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 244.7 lb, was diagnosed with blood glucose abnormal and. Glipizide dosage: 5 Mg, 3x/day. During the same period patient was treated with ANTIHYPERTENSIVES (Unk) (View Antihypertensives Review and Antihypertensives Label ).

6912864-8 | Weight Increased
Adverse event was reported on Feb 25, 2009 by a Female patient taking Glipizide (View Usage) (Dosage: ) . Location: UNITED STATES , 81 years of age, Patient experienced the following unwanted or unexpected effects: weight increased.

6912818-1 | Blood Glucose Fluctuation, Constipation, Glycosylated Haemoglobin Increased
on Jan 07, 2009 Male patient from UNITED STATES , weighting 160.1 lb, was diagnosed with type 2 diabetes mellitus and was treated with Glipizide (View Usage). Patient had the following side effects: blood glucose fluctuation, constipation (What is constipation?), glycosylated haemoglobin increased. Glipizide dosage: . During the same period patient was treated with METFORMIN (Unk) (View Metformin Review and Metformin Label ), ZETIA (Unk) (View Zetia Review and Zetia Label ), CRESTOR (Unk) (View Crestor Review and Crestor Label ), VITAMIN TAB (Unk) (View Vitamin Tab Review and Vitamin Tab Label ).

6912719-9 | Feeling Abnormal
on Oct 16, 2008 Female patient from UNITED STATES , weighting 212.0 lb, was diagnosed with diabetes mellitus and was treated with Glipizide (View Usage). After Glipizide was administered, patient had the following side effects: feeling abnormal. Glipizide dosage: . During the same period patient was treated with COREG (View Coreg Review and Coreg Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), RESTORIL (View Restoril Review and Restoril Label ).

6912648-0 | Diarrhoea
Patient was taking Glipizide (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea on Sep 19, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 165.3 lb, was diagnosed with diabetes mellitus and. Glipizide dosage: . During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).

6912578-4 | Blood Glucose Fluctuation
Adverse event was reported on Jul 15, 2008 by a Male patient taking Glipizide (View Usage) (Dosage: ) was diagnosed with blood glucose abnormal, diabetes mellitus and. Location: UNITED STATES , weighting 190.4 lb, Patient had the following side effects: blood glucose fluctuation. During the same period patient was treated with GLUCOTROL XL (View Glucotrol Xl Review and Glucotrol Xl Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).

6912525-5 | Memory Impairment, Mood Altered
on Jun 23, 2008 Female patient from UNITED STATES , weighting 114.2 lb, was diagnosed with diabetes mellitus and was treated with Glipizide (View Usage). After Glipizide was administered, patient had the following side effects: memory impairment, mood altered. Glipizide dosage: . During the same period patient was treated with OSTEO BI FLEX (View Osteo Bi-flex Review and Osteo Bi-flex Label ), ZOCOR (View Zocor Review and Zocor Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), HYDRALAZINE HCL (View Hydralazine Hcl Review and Hydralazine Hcl Label ), ISOSORBIDE (View Isosorbide Review and Isosorbide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), BABYPRIN (View Babyprin Review and Babyprin Label ).

6912457-2 | Blood Glucose Increased
on May 27, 2008 Male patient from UNITED STATES , weighting 270.6 lb, was diagnosed with diabetes mellitus and was treated with Glipizide (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased. Glipizide dosage: . During the same period patient was treated with QUINAPRIL (View Quinapril Review and Quinapril Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ACTOS (View Actos Review and Actos Label ).

6912428-6 | Blood Glucose Increased
Patient was taking Glipizide (View Usage). Patient had the following side effects: blood glucose increased on Jun 16, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 223.5 lb, was diagnosed with type 2 diabetes mellitus and. Glipizide dosage: . During the same period patient was treated with VITAMIN TAB (View Vitamin Tab Review and Vitamin Tab Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), PRINIVIL (View Prinivil Review and Prinivil Label ), PLENDIL (View Plendil Review and Plendil Label ), ARIXTRA (View Arixtra Review and Arixtra Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), LASIX (View Lasix Review and Lasix Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ).

6912416-X | Blood Creatinine Increased, Blood Urea Increased
Adverse event was reported on Apr 02, 2008 by a Male patient taking Glipizide (View Usage) (Dosage: ) was diagnosed with diabetes mellitus and. Location: UNITED STATES , weighting 150.3 lb, After Glipizide was administered, patient had the following side effects: blood creatinine increased, blood urea increased. During the same period patient was treated with CHOLESTEROL AND TRIGLYCERIDE REDUCERS (View Cholesterol- And Triglyceride Reducers Review and Cholesterol- And Triglyceride Reducers Label ), ANTIHYPERTENSIVES (View Antihypertensives Review and Antihypertensives Label ).

6912286-X | Asthenia, Blood Glucose Decreased, Blood Pressure Increased, Confusional State, Hyperhidrosis, Memory Impairment, Palpitations, Unevaluable Event
on Feb 24, 2008 Female patient from UNITED STATES , weighting 149.9 lb, was diagnosed with blood glucose increased and was treated with Glipizide (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, blood glucose decreased, blood pressure increased, confusional state, hyperhidrosis, memory impairment, palpitations, unevaluable event. Glipizide dosage: . During the same period patient was treated with CELEBREX (View Celebrex Review and Celebrex Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PHENAZOPYRIDINE HCL TAB (View Phenazopyridine Hcl Tab Review and Phenazopyridine Hcl Tab Label ).

6912273-1 | Unevaluable Event
on May 16, 2008 Female patient from UNITED STATES , 64 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Glipizide (View Usage). Patient had the following side effects: unevaluable event. Glipizide dosage: . During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), TRAMADOL HYDROCHLORIDE (View Tramadol Hydrochloride Review and Tramadol Hydrochloride Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), DOXEPIN HCL (View Doxepin Hcl Review and Doxepin Hcl Label ).

6911897-5 | Abdominal Distension, Abdominal Pain, Abdominal Pain Upper, Constipation, Diarrhoea, Flatulence
Patient was taking Glipizide (View Usage). After Glipizide was administered, patient had the following side effects: abdominal distension, abdominal pain (What is abdominal pain?), abdominal pain upper, constipation (What is constipation?), diarrhoea, flatulence on Oct 08, 2007 from UNITED STATES Additional patient health information: Female patient , weighting 160.0 lb, was diagnosed with diabetes mellitus and. Glipizide dosage: . During the same period patient was treated with GLUCOPHAGE (View Glucophage Review and Glucophage Label ), AMITRIL (View Amitril Review and Amitril Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), LIPITOR (View Lipitor Review and Lipitor Label ), AMARYL (View Amaryl Review and Amaryl Label ), AVANDIA (View Avandia Review and Avandia Label ).

6911871-9 | Blood Glucose Increased, Nausea
Adverse event was reported on Sep 25, 2007 by a Female patient taking Glipizide (View Usage) (Dosage: ) was diagnosed with diabetes mellitus and. Location: UNITED STATES , 61 years of age, Patient experienced the following unwanted or unexpected effects: blood glucose increased, nausea (What is nausea?).

6911833-1 | Blood Glucose Increased, Hyperglycaemia
on Aug 13, 2007 Male patient from UNITED STATES , weighting 160.0 lb, was diagnosed with type 2 diabetes mellitus, blood cholesterol increased, prostatic disorder and was treated with Glipizide (View Usage). Patient had the following side effects: blood glucose increased, hyperglycaemia. Glipizide dosage: . During the same period patient was treated with GEMFIBROZIL (View Gemfibrozil Review and Gemfibrozil Label ), VITAMIN E (View Vitamin E Review and Vitamin E Label ), SAW PALMETTO (View Saw Palmetto Review and Saw Palmetto Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ).

6875067-1 | Blood Glucose Fluctuation, Blood Glucose Increased
on May 18, 2010 Male patient from UNITED STATES , 64 years of age, was treated with Glipizide (View Usage). After Glipizide was administered, patient had the following side effects: blood glucose fluctuation, blood glucose increased. Glipizide dosage: . During the same period patient was treated with AVANDAMET (View Avandamet Review and Avandamet Label ), LANTUS /01483501/ (View Lantus /01483501/ Review and Lantus /01483501/ Label ).

6875065-8 | Hypersensitivity, Retching
Patient was taking Glipizide (View Usage). Patient experienced the following unwanted or unexpected effects: hypersensitivity, retching on May 03, 2010 from UNITED STATES Additional patient health information: Female patient , 52 years of age, was diagnosed with diabetes mellitus and. Glipizide dosage: .

6875063-4 | Blood Glucose Increased, Haemoptysis
Adverse event was reported on Mar 23, 2010 by a Male patient taking Glipizide (View Usage) (Dosage: ) was diagnosed with blood glucose and. Location: UNITED STATES , 73 years of age, Patient had the following side effects: blood glucose increased, haemoptysis.

6875062-2 | Blood Glucose Increased
on Feb 23, 2010 Female patient from UNITED STATES , 64 years of age, weighting 176.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with Glipizide (View Usage). After Glipizide was administered, patient had the following side effects: blood glucose increased. Glipizide dosage: . During the same period patient was treated with ACCUPRIL (View Accupril Review and Accupril Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ).

6875056-7 | Abdominal Distension, Increased Appetite, Weight Increased
on Nov 05, 2009 Female patient from UNITED STATES , weighting 170.0 lb, was diagnosed with diabetes mellitus and was treated with Glipizide (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, increased appetite, weight increased. Glipizide dosage: .

6847516-6 | Pancreatic Carcinoma
Patient was taking Glipizide (View Usage). Patient had the following side effects: pancreatic carcinoma on Jul 06, 2010 from UNITED STATES Additional patient health information: Male patient , 67 years of age, . Glipizide dosage: 5 Mg Once Daily And Also 2.5 Mg Once Daily.

6840739-1 | Dermatitis Bullous, Erythema, Skin Erosion, Stomatitis, Toxic Epidermal Necrolysis
Adverse event was reported on Jul 02, 2010 by a Female patient taking Glipizide (View Usage) (Dosage: 2.5 Mg, 1x/day) was diagnosed with diabetes mellitus, gout (What is gout?), hypertension and. Location: SINGAPORE , 73 years of age, After Glipizide was administered, patient had the following side effects: dermatitis bullous, erythema, skin erosion, stomatitis, toxic epidermal necrolysis. During the same period patient was treated with ALLOPURINOL (100 Mg, 1x/day) (View Allopurinol Review and Allopurinol Label ), CARVEDILOL (6.25 Mg, 2x/day) (View Carvedilol Review and Carvedilol Label ).

6825836-9 | Tablet Issue
on Jul 08, 2010 Female patient from UNITED STATES , weighting 158.0 lb, was treated with Glipizide (View Usage). Patient experienced the following unwanted or unexpected effects: tablet issue. Glipizide dosage: 2.5 Mg 1 Daily 2/3 Years Or More.

6822148-4 | Thrombocytopenia
on Jul 06, 2010 Male patient from UNITED STATES , 68 years of age, weighting 196.4 lb, was diagnosed with diabetes mellitus and was treated with Glipizide (View Usage). Patient had the following side effects: thrombocytopenia. Glipizide dosage: 5 Mg Bid Po. Patient was hospitalized.

6820240-1 | Blood Glucose Increased, Rash
Patient was taking Glipizide (View Usage). After Glipizide was administered, patient had the following side effects: blood glucose increased, rash (What is rash?) on Jun 29, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 187.0 lb, was diagnosed with diabetes mellitus, hypertension, blood cholesterol abnormal and. Glipizide dosage: 5 Mg, 2x/day. During the same period patient was treated with METFORMIN HCL (Unk) (View Metformin Hcl Review and Metformin Hcl Label ), NIACIN (500 Mg, 1x/day) (View Niacin Review and Niacin Label ), BENAZEPRIL (20 Mg, 1x/day) (View Benazepril Review and Benazepril Label ), HYDROCHLOROTHIAZIDE (12.5 Mg, 1x/day) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ZETIA (10 Mg, 1x/day) (View Zetia Review and Zetia Label ), TRICOR (145 Mg, 1x/day) (View Tricor Review and Tricor Label ), WARFARIN (5 Mg, 1x/day) (View Warfarin Review and Warfarin Label ), FISH OIL (2 G, 2x/day) (View Fish Oil Review and Fish Oil Label ).

6786098-4 | Hypoglycaemia
Adverse event was reported on Jun 21, 2010 by a Male patient taking Glipizide (View Usage) (Dosage: 20 Mg Bid Po) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , 60 years of age, weighting 160.1 lb, Patient experienced the following unwanted or unexpected effects: hypoglycaemia. During the same period patient was treated with INSULIN (37 Units Every Day Sq) (View Insulin Review and Insulin Label ). Patient was hospitalized.

6744355-1 | Hypoglycaemia, Hypophagia, Unresponsive To Stimuli
on May 26, 2010 Male patient from UNITED STATES , 69 years of age, weighting 159.2 lb, was diagnosed with type 2 diabetes mellitus and was treated with Glipizide (View Usage). Patient had the following side effects: hypoglycaemia, hypophagia, unresponsive to stimuli. Glipizide dosage: 5 Mg Bid Po. Patient was hospitalized.

6743312-9 | Pulmonary Thrombosis
on May 19, 2010 Female patient from UNITED STATES , 71 years of age, was diagnosed with diabetes mellitus and was treated with Glipizide (View Usage). After Glipizide was administered, patient had the following side effects: pulmonary thrombosis. Glipizide dosage: . During the same period patient was treated with AVANDIA (View Avandia Review and Avandia Label ). Patient was hospitalized.

6743311-7 | Pulmonary Thrombosis
Patient was taking Glipizide (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary thrombosis on May 19, 2010 from UNITED STATES Additional patient health information: Female patient , 71 years of age, was diagnosed with diabetes mellitus and. Glipizide dosage: . During the same period patient was treated with AVANDIA (View Avandia Review and Avandia Label ). Patient was hospitalized.

6733538-2 | Glycosylated Haemoglobin Increased
Adverse event was reported on May 10, 2010 by a Male patient taking Glipizide (View Usage) (Dosage: 20 Mg, Unk) . Location: UNITED STATES , 49 years of age, Patient had the following side effects: glycosylated haemoglobin increased.

6732484-8 | Dizziness, Vision Blurred
on May 07, 2010 Female patient from SINGAPORE , 54 years of age, was treated with Glipizide (View Usage). After Glipizide was administered, patient had the following side effects: dizziness (What is dizziness?), vision blurred. Glipizide dosage: .

6731409-9 | Alcohol Use, Hypoglycaemia, Unresponsive To Stimuli
on May 18, 2010 Male patient from UNITED STATES , 61 years of age, weighting 149.9 lb, was diagnosed with diabetes mellitus and was treated with Glipizide (View Usage). Patient experienced the following unwanted or unexpected effects: alcohol use, hypoglycaemia, unresponsive to stimuli. Glipizide dosage: 10 Mg Bid Po. Patient was hospitalized.

6720352-7 | Hypersensitivity
Patient was taking Glipizide (View Usage). Patient had the following side effects: hypersensitivity on Apr 30, 2010 from UNITED STATES Additional patient health information: Male patient , 95 years of age, . Glipizide dosage: .